NVST Envista Holdings Corp
HealthcareAs of 2026-05-25
Valuation
View DetailsP/E (TTM)
88.48
PEG
0.85
P/B
1.25
P/S
1.36
EV/EBITDA
12.63
DCF Value
$48.31
FCF Yield
5.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
55.1%
Operating Margin
9.0%
Net Margin
2.4%
ROE
2.2%
ROA
1.2%
ROIC
1.8%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $705.5M | $38.7M | $— |
| Q4 null | $750.6M | $32.9M | $— |
| FY null | $2.72B | $47.0M | $— |
| Q3 null | $669.9M | $-30.3M | $— |
Analyst Ratings
View AllConsensus
Hold
Target (Consensus)
$27.44
Target (Median)
$25.00
Target Range
$19.00 - $35.00
Trading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
Medical - Equipment & Services
Country
US
Exchange
—
Beta
0.93
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.